Latest Laboratory of Molecular Biology Stories

WELWYN GARDEN CITY, England, and BOSTON, June 19, 2012 /PRNewswire/ -- Heptares Therapeutics, the leading GPCR drug discovery company, has extended its collaboration with the UK Medical Research Council (MRC), including its leading research groups at the MRC Laboratory of Molecular Biology (LMB, Cambridge, UK) and MRC National Institute of Medical Research (NIMR, London, UK), on the structure and active conformations of G-protein coupled receptors (GPCRs), and other...

GENEVA, Sept. 27, 2011 /PRNewswire/ -- Selexis SA announced today it has appointed three leading, internationally recognized scientists to its newly formed Scientific Advisory Board (SAB). The appointed members bring expertise in the areas of gene expression and cell line development, monoclonal antibodies and therapeutic proteins. Selexis formed the SAB to expand the Company's SURE Technology Platform(TM) into the significant drug discovery and R&D market segments. The SAB members...

British scientists have developed a new way of joining and rebuilding molecules to refine the anti-wrinkle treatment Botox and improve its use for Parkinson's, cerebral palsy, and chronic migraine. Researchers at the Medical Research Council's Laboratory of Molecular Biology said their results opens up new ways to help develop new types of Botox, which may be used as long-term painkillers. "It will now be possible to produce Botox-based medicines in a safer and more economical way,"...

VIENNA, Austria, March 12 /PRNewswire/ -- f-star, an antibody engineering company developing novel antibodies and antibody fragments based on its unique Modular Antibody Technology, announced today that it will open a research facility in Cambridge, UK in addition to its headquarters in Vienna, Austria. The facility will be located at the Babraham Research Campus, home to a number of biotech companies and close to the Medical Research Council's Laboratory of Molecular Biology (LMB), the...